Literature DB >> 18784450

Photodynamic therapy treatment for eyes with drusenoid pigment epithelium detachment.

Na Young Lee1, Ki Seok Kim.   

Abstract

We report the clinical course of photodynamic therapy (PDT) in a patient with drusenoid pigment epithelium detachment (PED). A patient with drusenoid PED underwent PDT follow-up was carried out at one week, one month, three months, six months and one year after treatment. Fundus exam, optical coherence tomography (OCT) and fluorescein angiography were performed. After the PDT, drusen and PED were gradually diminished over one year. However, pure serous PED eventually developed at the same location of the drusenoid PED. The results of the PDT, on drusenoid PED, were initially effective, but not completely successful. Therefore, PDT may be considered as an alternative treatment option for drusenoid PED.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18784450      PMCID： PMC2629895          DOI： 10.3341/kjo.2008.22.3.194

Source DB:  PubMed          Journal:  Korean J Ophthalmol        ISSN： 1011-8942


  6 in total

1.  Pigment epithelial detachment in the elderly. Clinical differentiation, natural course and pathogenetic implications.

Authors:  D Pauleikhoff; D Löffert; G Spital; M Radermacher; J Dohrmann; A Lommatzsch; A C Bird
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2002-06-25       Impact factor: 3.117

2.  Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1999-10

3.  Laser-induced drusen reduction improves visual function at 1 year. Choroidal Neovascularization Prevention Trial Research Group.

Authors:  A C Ho; M G Maguire; J Yoken; M S Lee; D S Shin; N B Javornik; S L Fine
Journal:  Ophthalmology       Date:  1999-07       Impact factor: 12.079

4.  Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynamic therapy report 2.

Authors: 
Journal:  Am J Ophthalmol       Date:  2001-05       Impact factor: 5.258

5.  Clinical features of drusenoid pigment epithelial detachment in age related macular degeneration.

Authors:  W Roquet; F Roudot-Thoraval; G Coscas; G Soubrane
Journal:  Br J Ophthalmol       Date:  2004-05       Impact factor: 4.638

6.  Prophylactic laser treatment in early age related maculopathy reduced the incidence of exudative complications.

Authors:  C Frennesson; S E Nilsson
Journal:  Br J Ophthalmol       Date:  1998-10       Impact factor: 4.638
  6 in total
  5 in total

1.  Multimodal evaluation of macular function in age-related macular degeneration.

Authors:  Ken Ogino; Akitaka Tsujikawa; Kenji Yamashiro; Sotaro Ooto; Akio Oishi; Isao Nakata; Masahiro Miyake; Ayako Takahashi; Abdallah A Ellabban; Nagahisa Yoshimura
Journal:  Jpn J Ophthalmol       Date:  2013-12-12       Impact factor: 2.447

2.  Intravitreal ranibizumab for symptomatic drusenoid pigment epithelial detachment without choroidal neovascularization in age-related macular degeneration.

Authors:  Roberto Gallego-Pinazo; Ana Marina; Ester Francés-Muñoz; J María Millán; J Fernando Arevalo; J Luis Mullor; Manuel Díaz-Llopis
Journal:  Clin Ophthalmol       Date:  2011-02-08

3.  Morphologic Changes in Patient with Drusen and Drusenoid Pigment Epithelial Detachment after Intravitreal Ranibizumab for Choroidal Neovascular Membrane : A Case Report.

Authors:  Sukjin Kim; Jeongjae Oh; Kiseok Kim
Journal:  Open Ophthalmol J       Date:  2016-02-04

4.  Treatment of large avascular retinal pigment epithelium detachments in age-related macular degeneration with aflibercept, photodynamic therapy, and triamcinolone acetonide.

Authors:  Arnt-Ole Tvenning; Christian Hedels; Jørgen Krohn; Dordi Austeng
Journal:  Clin Ophthalmol       Date:  2019-02-01

5.  Laser and anti-vascular endothelial growth factor treatment for drusenoid pigment epithelial detachment in age-related macular degeneration.

Authors:  Min Seok Kim; Na-Kyung Ryoo; Kyu Hyung Park
Journal:  Sci Rep       Date:  2020-09-01       Impact factor: 4.379
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.